Sara Baglivo
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Tissue and circulating biomarkers in advanced melanoma patients receiving dabrafenib and trametinib.
Tissue and circulating biomarkers in advanced melanoma patients receiving dabrafenib and trametinib.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 26, 2026
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.
Journal: Clinical and experimental medicine
Published: April 12, 2024
Correction: Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Journal: Oncology and therapy
Published: January 03, 2024
Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Journal: Oncology and therapy
Published: September 18, 2023
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.
Journal: Journal of chemotherapy (Florence, Italy)
Published: December 20, 2022
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 26, 2022
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Journal: Translational oncology
Published: February 18, 2022
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature.
Journal: Oncology and therapy
Published: December 01, 2021
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas.
Journal: Genes
Published: August 04, 2021
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: March 16, 2021
Last Updated: 09/26/2026